Skip to content
  • Sunday, 26 July 2026
  • 3:07 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • The First Blueprint of Human Skeletal Development Maps the Cellular Origins of Arthritis and Congenital Bone Conditions
Stem Cell & Regenerative Medicine

The First Blueprint of Human Skeletal Development Maps the Cellular Origins of Arthritis and Congenital Bone Conditions

Dwi Wanna Jul 10, 2026 0

In a landmark achievement for regenerative medicine and developmental biology, researchers from the Wellcome Sanger Institute and their international collaborators…

Read More
Stem Cell & Regenerative Medicine

Landmark Human Skeletal Atlas Reveals Developmental Blueprints and New Insights into Arthritis and Congenital Bone Conditions

Dwi Wanna May 27, 2026 0

Researchers from the Wellcome Sanger Institute, in collaboration with an international network of scientists, have unveiled the first comprehensive "blueprint"…

Read More
Stem Cell & Regenerative Medicine

Human Skeletal Development Blueprint Reveals New Insights into Arthritis and Congenital Bone Conditions

Dwi Wanna May 5, 2026 0

In a landmark achievement for regenerative medicine and developmental biology, researchers have unveiled the first comprehensive "blueprint" of human skeletal…

Read More
Stem Cell & Regenerative Medicine

First Blueprint of Human Skeletal Development Reveals Cellular Origins of Arthritis and Congenital Bone Conditions

Dwi Wanna Mar 23, 2026 0

Researchers from the Wellcome Sanger Institute and their international collaborators have achieved a significant scientific milestone by mapping the first…

Read More
Mapping the Foundations of Human Life First Blueprint of Skeletal Development Unveils Origins of Arthritis and Rare Bone ConditionsUnlocking the Genetic Keys to GLP-1 Drug Efficacy and Side EffectsResearchers Identify Cellular Energy Deficits as Key Biological Marker for Early Stage Major DepressionTWiV 1293: The enemy of your parasite is your friend
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ